Select Equity Group’s Colgate-Palmolive CL Stock Holding History

Select Equity Group’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-261,871	Closed	-$17M	–	109
2014 Q1	$17M	Sell	261,871 -6,857	-3%	-$432K	0.19%	76
2013 Q4	$17.5M	Buy	+268,728	New	+$17.2M	0.18%	84

Other funds holding CL

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Select Equity Group's CL Position: Q2 2014 in Review

Select Equity Group sold out of Colgate-Palmolive (CL) in Q2 2014, closing a stake of 261,871 shares — an estimated $17M sold.

Select Equity Group first reported a position in CL in Q4 2013 and held it in 2 quarters. The position peaked at $17.5M in Q4 2013. 1,193 funds tracked by Wall St. Rank hold CL as of Q2 2014.

Select Equity Group reported no remaining Colgate-Palmolive position as of Q2 2014 after selling out during the quarter.
Select Equity Group sold 261,871 Colgate-Palmolive shares in Q2 2014, an estimated $17M.
Select Equity Group first reported a position in Colgate-Palmolive in Q4 2013 and held it in 2 quarters.
Select Equity Group's Colgate-Palmolive position peaked at $17.5M in Q4 2013.
1,193 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2014.

Based on Select Equity Group's 13F filing for Q2 2014, filed 14 Aug 2014.